Moolec Science Financials - Benzinga

Moolec Science SA

MLECNASDAQ

Trade with Public

Trade with Public

$8.26

1.3719.8%

Last update: Sep 2, 4:03 AM

Overview News Earnings Forecast Price TargetsFinancialsSentiment Compare Stock Report

Moolec Science Financials

Moolec Science (MLEC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Moolec Science Q4 2024 GAAP EPS $(0.07) Misses $(0.06) Estimate, Sales $1.523M Beat $1.255M Estimate

Benzinga Newsdesk

PRO
Moolec Science Q2 EPS $(0.05) Beats $(0.07) Estimate, Sales $252.10K Miss $600.00K Estimate

Moolec Science (NASDAQ:MLEC) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. The company reported quarterly sales of $252.10 thousand which missed

Benzinga Newsdesk

Earnings Scheduled For March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Benzinga Insights

US Stocks Higher; Inflation Rate Increases To 3.4% In December

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.07% to 37,723.53 while the NASDAQ rose 0.46% to 15,039.09. The S&P 500 also rose, gaining, 0.21% to 4,793.32.

Avi Kapoor

PRO
Moolec Science Q1 Revenue Increase 92% Q/Q To $1.74M Given Given Full Quarter Consolidation Of Acquired Business And Higher Volume And Prices

Benzinga Newsdesk

Nasdaq Down 50 Points; US Home Price Index Rises In February

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.01% to 33,872.34 while the NASDAQ fell 0.45% to 11,983.04. The S&P 500, also fell, dropping, 0.36% to 4,122.01.

Lisa Levin